[Skip to Navigation]
November 1962

Continuous Antibiotic Prophylaxis and the Staphylococcal Carrier

Author Affiliations


Formerly Fellow in Preventive Medicine and EIS Officer, Public Health Service, Department of Health, Education, and Welfare, Communicable Disease Center (Dr. Novack); Professor of Preventive Medicine (Dr. Feldman).; From the Department of Preventive Medicine, State University of New York, Upstate Medical Center.

Arch Intern Med. 1962;110(5):726-734. doi:10.1001/archinte.1962.03620230172023

While general recognition of the emergence of antibiotic-resistant, coagulase-positive staphylococci in both hospitals1-4 and communities5,6 has led to extensive reinvestigation of this organism, our knowledge of its epidemiology in the nonhospital environment remains inadequate. The presence of resistant Staphylococcus aureus in the community has been related by some7,8 to recent hospitalization and treatment with antibiotics. A recent Australian study showed that 64% of S. aureus strains isolated from the purulent lesions of patients who were seen in doctors' offices were resistant to penicillin.9 Others,10-13 who have studied people who were receiving continuous prophylactic antibiotic medication, have reported that such individuals become carriers of resistant organisms more often than does the population at large.

In an effort to determine more accurately the relation between coagulase-positive staphylococci and non-hospital-centered persons, we have been conducting several long-term surveillance programs in different population groups. A preliminary report14 of

Add or change institution